Add BrightSurf on Google Email

Center for Genomic Regulation


Researchers perform thousands of mutations to understand amyotrophic lateral sclerosis

Amyotrophic Lateral Sclerosis (ALS) researchers found that aggregation of TDP-43 is not harmful but actually protects cells. This discovery challenges the assumption that alleviating protein aggregates is necessary to treat neurodegenerative diseases like ALS. The study opens doors to radically new therapeutic approaches if aggregation...

SourceCenter for Genomic Regulation·JournalNature Communications·DateSep 23, 2019

The inflammation connection

Researchers at the Center for Genomic Regulation discovered a novel way to control inflammation by understanding how cells produce IL-1β, a crucial molecule involved in inflammation. By targeting the unfolded protein response and GRASP55 pathways, they identified potential avenues for developing anti-inflammatory drugs.

SourceCenter for Genomic Regulation·JournalDevelopmental Cell·DateApr 1, 2019

LifeTime is delighted to receive EU funding

The European Commission has awarded €1 million in funding to the LifeTime initiative, a six-year research project that will integrate single-cell methods, personalized organoids, and machine learning to understand human cells when diseases develop. The goal is to fundamentally improve patient care and set the basis for precision medicine.

Binge-eating mice reveal obesity clues

Mice fed on high-fat or chocolate-based diets exhibit abnormal feeding behaviors such as snacking and bingeing. The study reveals that extended access to hypercaloric diets impairs control of food seeking behavior, leading to negative effects on learning, motivation, and behavioral flexibility.

SourceCenter for Genomic Regulation·JournalAddiction Biology·DateApr 9, 2018